Substance
ID:346901
Names and Identifiers
IUPAC Traditional name
zaleplon
IUPAC name
N-(3-{3-cyanopyrazolo[1,5-a]pyrimidin-7-yl}phenyl)-N-ethylacetamide
Synonyms
CL-284846ZaleplonN-[3-(3-Cyanopyrazolo-[1,5-a]pyrimidin-7-yl)phenyl)-N-ethylacetamide
Properties
Safety Information
GHS Pictograms
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Storage Condition
desiccated
protect from light
Drug Control
USDEA Schedule IV; psychotrope; regulated under CDSA - not available from Sigma-Aldrich Canada
GHS Signal Word
Warning
GHS Hazard statements
H315-H319-H335
GHS Precautionary statements
P261-P305+P351+P338
Risk Statements
36/37/38
Storage Temperature
2-8°C
European Hazard Symbols
Irritant (Xi)MSDS Link
Safety Statements
26-36
German water hazard class
3
Physical Property
Apperance
white solid
Solubility
H2O: insoluble
DMSO: ~20 mg/mL
Product Information
Purity
≥98% (HPLC)
Empirical Formula (Hill Notation)
C17H15N5O
Molecule Details
Biochem/physiol Actions
Zaleplon is a non-benzodiazepine agonist at the benzodiazepine site of the GABAA receptor; sedative; hypnotic.
Zaleplon is a non-benzodiazepine agonist at the benzodiazepine site of the GABAA receptor; sedative; hypnotic.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data